• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前瞻性、随机试验表明强化 SMBG 管理对非胰岛素治疗的 T2DM 患者有益(PRISMA):一项旨在确定结构化 SMBG 干预效果的研究。

Prospective, randomized trial on intensive SMBG management added value in non-insulin-treated T2DM patients (PRISMA): a study to determine the effect of a structured SMBG intervention.

机构信息

Diabetes Research Institute, San Raffaele Scientific Institute, Milan, Italy.

出版信息

Acta Diabetol. 2013 Oct;50(5):663-72. doi: 10.1007/s00592-011-0357-y. Epub 2011 Dec 22.

DOI:10.1007/s00592-011-0357-y
PMID:22189755
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3898142/
Abstract

Self-monitoring of blood glucose (SMBG) is a core component of diabetes management. However, the International Diabetes Federation recommends that SMBG be performed in a structured manner and that the data are accurately interpreted and used to take appropriate therapeutic actions. We designed a study to evaluate the impact of structured SMBG on glycemic control in non-insulin-treated type 2 diabetes (T2DM) patients. The Prospective, Randomized Trial on Intensive SMBG Management Added Value in Non-insulin-Treated T2DM Patients (PRISMA) is a 12-month, prospective, multicenter, open, parallel group, randomized, and controlled trial to evaluate the added value of an intensive, structured SMBG regimen in T2DM patients treated with oral agents and/or diet. One thousand patients (500 per arm) will be enrolled at 39 clinical sites in Italy. Eligible patients will be randomized to the intensive structured monitoring (ISM) group or the active control (AC) group, with a glycosylated hemoglobin (HbA1c) target of <7.0%. Intervention will comprise (1) structured SMBG (4-point daily glucose profiles on 3 days per week [ISM]; discretionary, unstructured SMBG [AC]); (2) comprehensive patient education (both groups); and (3) clinician's adjustment of diabetes medications using an algorithm targeting SMBG levels, HbA1c and hypoglycemia (ISM) or HbA1c and hypoglycemia (AC). The intervention and trial design build upon previous research by emphasizing appropriate and collaborative use of SMBG by both patients and physicians. Utilization of per protocol and intent-to-treat analyses facilitates assessment of the intervention. Inclusion of multiple dependent variables allows us to assess the broader impact of the intervention, including changes in patient and physician attitudes and behaviors.

摘要

自我血糖监测(SMBG)是糖尿病管理的核心组成部分。然而,国际糖尿病联合会建议 SMBG 应以结构化的方式进行,并且数据应准确解释并用于采取适当的治疗措施。我们设计了一项研究来评估结构化 SMBG 对未经胰岛素治疗的 2 型糖尿病(T2DM)患者血糖控制的影响。前瞻性、随机试验强化 SMBG 管理对未经胰岛素治疗的 T2DM 患者的附加价值(PRISMA)是一项为期 12 个月的前瞻性、多中心、开放、平行组、随机对照试验,旨在评估强化、结构化 SMBG 方案在口服药物和/或饮食治疗的 T2DM 患者中的附加价值。将在意大利的 39 个临床站点招募 1000 名患者(每组 500 名)。符合条件的患者将被随机分配到强化结构化监测(ISM)组或主动对照(AC)组,糖化血红蛋白(HbA1c)目标值<7.0%。干预措施包括(1)结构化 SMBG(每周 3 天每天 4 点血糖谱[ISM];随意、非结构化 SMBG[AC]);(2)综合患者教育(两组);(3)使用针对 SMBG 水平、HbA1c 和低血糖的算法调整糖尿病药物,由临床医生根据 SMBG 水平、HbA1c 和低血糖进行调整(ISM)或 HbA1c 和低血糖(AC)。干预和试验设计基于之前的研究,强调患者和医生适当且协作地使用 SMBG。使用符合方案和意向治疗分析有助于评估干预措施。纳入多个因变量可以评估干预措施的更广泛影响,包括患者和医生态度和行为的变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5797/3898142/c13d6cf24b2d/592_2011_357_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5797/3898142/7e3396a54903/592_2011_357_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5797/3898142/993a86bd7a92/592_2011_357_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5797/3898142/c13d6cf24b2d/592_2011_357_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5797/3898142/7e3396a54903/592_2011_357_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5797/3898142/993a86bd7a92/592_2011_357_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5797/3898142/c13d6cf24b2d/592_2011_357_Fig3_HTML.jpg

相似文献

1
Prospective, randomized trial on intensive SMBG management added value in non-insulin-treated T2DM patients (PRISMA): a study to determine the effect of a structured SMBG intervention.前瞻性、随机试验表明强化 SMBG 管理对非胰岛素治疗的 T2DM 患者有益(PRISMA):一项旨在确定结构化 SMBG 干预效果的研究。
Acta Diabetol. 2013 Oct;50(5):663-72. doi: 10.1007/s00592-011-0357-y. Epub 2011 Dec 22.
2
The value of episodic, intensive blood glucose monitoring in non-insulin treated persons with Type 2 Diabetes: design of the Structured Testing Program (STeP) study, a cluster-randomised, clinical trial [NCT00674986].非胰岛素治疗的 2 型糖尿病患者间歇性密集血糖监测的价值:结构化测试计划 (STeP) 研究的设计,一项集群随机、临床试验 [NCT00674986]。
BMC Fam Pract. 2010 May 18;11:37. doi: 10.1186/1471-2296-11-37.
3
Structured self-monitoring of blood glucose regimens improve glycemic control in poorly controlled Chinese patients on insulin therapy: Results from COMPASS.结构化血糖自我监测方案可改善胰岛素治疗的中国血糖控制不佳患者的血糖控制:COMPASS研究结果
J Diabetes. 2017 May;9(5):495-501. doi: 10.1111/1753-0407.12434. Epub 2016 Aug 21.
4
Intensive structured self-monitoring of blood glucose and glycemic control in noninsulin-treated type 2 diabetes: the PRISMA randomized trial.非胰岛素治疗的 2 型糖尿病患者强化结构化自我血糖监测与血糖控制:PRISMA 随机试验。
Diabetes Care. 2013 Oct;36(10):2887-94. doi: 10.2337/dc13-0092. Epub 2013 Jun 4.
5
A structured self-monitoring of blood glucose approach in type 2 diabetes encourages more frequent, intensive, and effective physician interventions: results from the STeP study.结构化自我血糖监测在 2 型糖尿病中的应用鼓励更频繁、更密集、更有效的医生干预:来自 STEP 研究的结果。
Diabetes Technol Ther. 2011 Aug;13(8):797-802. doi: 10.1089/dia.2011.0073. Epub 2011 May 13.
6
Effects of physician's diabetes self-management education using Japan Association of Diabetes Education and Care Diabetes Education Card System Program and a self-monitoring of blood glucose readings analyzer in individuals with type 2 diabetes: An exploratory, open-labeled, prospective randomized clinical trial.采用日本糖尿病教育与护理协会糖尿病教育卡片系统方案和自我血糖监测读数分析仪对 2 型糖尿病患者进行医生糖尿病自我管理教育的效果:一项探索性、开放性、前瞻性随机临床试验。
J Diabetes Investig. 2021 Dec;12(12):2221-2231. doi: 10.1111/jdi.13607. Epub 2021 Jul 30.
7
Self-monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes (The SMBG Study): study protocol for a randomised controlled trial.非胰岛素治疗的2型糖尿病患者自我血糖监测(SMBG研究):一项随机对照试验的研究方案
BMC Endocr Disord. 2017 Jan 26;17(1):4. doi: 10.1186/s12902-017-0154-x.
8
Effects of Structured Versus Unstructured Self-Monitoring of Blood Glucose on Glucose Control in Patients With Non-insulin-treated Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.结构化与非结构化自我血糖监测对非胰岛素治疗的2型糖尿病患者血糖控制的影响:一项随机对照试验的荟萃分析
J Diabetes Sci Technol. 2018 Jan;12(1):183-189. doi: 10.1177/1932296817719290. Epub 2017 Jul 12.
9
Intermittently scanned continuous glucose monitoring provides no benefit over structured self-monitoring of blood glucose in type 2 diabetes not on prandial insulin, in the context of diabetes self-management education: GLucose monitoring programme SingaporE (GLiMPSE).在糖尿病自我管理教育的背景下,对于未使用餐前胰岛素的 2 型糖尿病患者,间歇性扫描连续血糖监测并未优于结构化的自我血糖监测:新加坡血糖监测计划(GLiMPSE)。
Diabetes Res Clin Pract. 2024 May;211:111678. doi: 10.1016/j.diabres.2024.111678. Epub 2024 Apr 18.
10
Impact of structured self-monitoring of blood glucose on the quality of life of insulin-treated Chinese patients with type 2 diabetes mellitus: Results from the COMPASS study.结构化血糖自我监测对接受胰岛素治疗的中国2型糖尿病患者生活质量的影响:COMPASS研究结果
Diabetes Res Clin Pract. 2016 Feb;112:88-93. doi: 10.1016/j.diabres.2015.08.004. Epub 2015 Sep 8.

引用本文的文献

1
A telemedicine-based approach with real-time transmission of blood glucose data improves metabolic control in insulin-treated diabetes: the DIAMONDS randomized clinical trial.基于实时血糖数据传输的远程医疗方法可改善胰岛素治疗糖尿病的代谢控制:DIAMONDS 随机临床试验。
J Endocrinol Invest. 2022 Sep;45(9):1663-1671. doi: 10.1007/s40618-022-01802-w. Epub 2022 Apr 27.
2
Diabetes management intervention studies: lessons learned from two studies.糖尿病管理干预研究:两项研究的经验教训。
Trials. 2021 Jan 18;22(1):61. doi: 10.1186/s13063-020-05017-3.
3
Long-Term Effect of the Color Record Method in Self-Monitoring of Blood Glucose on Metabolic Parameters in Type 2 Diabetes: A 2-Year Follow-up of the Color IMPACT Study.

本文引用的文献

1
ROSES: role of self-monitoring of blood glucose and intensive education in patients with Type 2 diabetes not receiving insulin. A pilot randomized clinical trial.ROSES:2 型糖尿病未接受胰岛素治疗患者的自我血糖监测和强化教育的作用。一项随机临床试验。
Diabet Med. 2011 Jul;28(7):789-96. doi: 10.1111/j.1464-5491.2011.03268.x.
2
Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study.结构化自我血糖监测可显著降低血糖控制不佳的非胰岛素治疗 2 型糖尿病患者的 A1C 水平:来自结构化检测计划研究的结果。
Diabetes Care. 2011 Feb;34(2):262-7. doi: 10.2337/dc10-1732.
3
血糖自我监测中颜色记录法对2型糖尿病代谢参数的长期影响:颜色影响研究的2年随访
Diabetes Ther. 2018 Aug;9(4):1501-1510. doi: 10.1007/s13300-018-0457-6. Epub 2018 Jun 12.
4
Effects of Structured Versus Unstructured Self-Monitoring of Blood Glucose on Glucose Control in Patients With Non-insulin-treated Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.结构化与非结构化自我血糖监测对非胰岛素治疗的2型糖尿病患者血糖控制的影响:一项随机对照试验的荟萃分析
J Diabetes Sci Technol. 2018 Jan;12(1):183-189. doi: 10.1177/1932296817719290. Epub 2017 Jul 12.
5
Impact on Diabetes Self-Management and Glycemic Control of a New Color-Based SMBG Meter.一款新型基于颜色的自我血糖监测仪对糖尿病自我管理和血糖控制的影响
J Diabetes Sci Technol. 2017 Nov;11(6):1218-1225. doi: 10.1177/1932296817706376. Epub 2017 Apr 26.
6
The Burden of Structured Self-Monitoring of Blood Glucose on Diabetes-Specific Quality of Life and Locus of Control in Patients with Noninsulin-Treated Type 2 Diabetes: The PRISMA Study.非胰岛素治疗的2型糖尿病患者血糖结构化自我监测对糖尿病特异性生活质量和控制源的负担:PRISMA研究
Diabetes Technol Ther. 2016 Jul;18(7):421-8. doi: 10.1089/dia.2015.0358. Epub 2016 Jun 21.
7
Intensified glucose self-monitoring with education in Saudi DM patients.沙特糖尿病患者强化血糖自我监测并接受相关教育。
Int J Clin Exp Med. 2015 Oct 15;8(10):19374-80. eCollection 2015.
8
Self-monitoring of blood glucose in diabetes: from evidence to clinical reality in Central and Eastern Europe--recommendations from the international Central-Eastern European expert group.糖尿病患者的血糖自我监测:从中东欧的证据到临床实践——中东欧国际专家组的建议
Diabetes Technol Ther. 2014 Jul;16(7):460-75. doi: 10.1089/dia.2013.0302. Epub 2014 Apr 9.
9
Intensive structured self-monitoring of blood glucose and glycemic control in noninsulin-treated type 2 diabetes: the PRISMA randomized trial.非胰岛素治疗的 2 型糖尿病患者强化结构化自我血糖监测与血糖控制:PRISMA 随机试验。
Diabetes Care. 2013 Oct;36(10):2887-94. doi: 10.2337/dc13-0092. Epub 2013 Jun 4.
10
Self-monitoring of blood glucose in type 2 diabetes: recent studies.2型糖尿病患者的血糖自我监测:近期研究
J Diabetes Sci Technol. 2013 Mar 1;7(2):478-88. doi: 10.1177/193229681300700225.
Standards of medical care in diabetes--2011.
《糖尿病医疗护理标准——2011 年》
Diabetes Care. 2011 Jan;34 Suppl 1(Suppl 1):S11-61. doi: 10.2337/dc11-S011.
4
Benefits of self-monitoring blood glucose in the management of new-onset Type 2 diabetes mellitus: the St Carlos Study, a prospective randomized clinic-based interventional study with parallel groups.自我监测血糖在新发 2 型糖尿病管理中的获益:圣卡洛斯研究,一项基于诊所的前瞻性随机干预研究,采用平行分组设计。
J Diabetes. 2010 Sep;2(3):203-11. doi: 10.1111/j.1753-0407.2010.00081.x.
5
ROSSO-in-praxi: a self-monitoring of blood glucose-structured 12-week lifestyle intervention significantly improves glucometabolic control of patients with type 2 diabetes mellitus.ROSSO-in-praxi:一种自我监测血糖的结构化 12 周生活方式干预,显著改善了 2 型糖尿病患者的糖代谢控制。
Diabetes Technol Ther. 2010 Jul;12(7):547-53. doi: 10.1089/dia.2010.0008.
6
The value of episodic, intensive blood glucose monitoring in non-insulin treated persons with Type 2 Diabetes: design of the Structured Testing Program (STeP) study, a cluster-randomised, clinical trial [NCT00674986].非胰岛素治疗的 2 型糖尿病患者间歇性密集血糖监测的价值:结构化测试计划 (STeP) 研究的设计,一项集群随机、临床试验 [NCT00674986]。
BMC Fam Pract. 2010 May 18;11:37. doi: 10.1186/1471-2296-11-37.
7
Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial.ACCORD 试验中血糖治疗中位 3.4 年随访期间 A1C 与全因死亡率的流行病学关系。
Diabetes Care. 2010 May;33(5):983-90. doi: 10.2337/dc09-1278.
8
Value of self-monitoring blood glucose pattern analysis in improving diabetes outcomes.自我血糖监测模式分析在改善糖尿病治疗效果中的价值。
J Diabetes Sci Technol. 2009 May 1;3(3):500-8. doi: 10.1177/193229680900300314.
9
Evaluation of a simple policy for pre- and post-prandial blood glucose self-monitoring in people with type 2 diabetes not on insulin.评估一种针对未使用胰岛素的 2 型糖尿病患者餐前和餐后血糖自我监测的简单策略。
Diabetes Res Clin Pract. 2010 Feb;87(2):246-51. doi: 10.1016/j.diabres.2009.10.021. Epub 2009 Dec 1.
10
Consensus report of the coalition for clinical research-self-monitoring of blood glucose.临床研究联盟关于血糖自我监测的共识报告。
J Diabetes Sci Technol. 2008 Nov;2(6):1030-53. doi: 10.1177/193229680800200612.